Show Summary Details
Page of

Implantable Cardioverter-Defibrillator Therapy in Women* 

Implantable Cardioverter-Defibrillator Therapy in Women*
Implantable Cardioverter-Defibrillator Therapy in Women*

Andrea M. Russo

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 12 April 2021

Randomized clinical trials have clearly demonstrated the efficacy of the implantable cardioverter-defibrillator (ICD) for the primary and secondary prevention of sudden cardiac death. However, the benefit of prophylactic ICD therapy in certain subgroups of patients, particularly women, has been questioned. This chapter discusses sex differences in outcome, including mortality and arrhythmic events during follow-up, complications, and use of ICD therapy in clinical practice.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.